NATCO Pharma Limited (NSE:NATCOPHARM)
818.50
+4.25 (0.52%)
At close: Jan 28, 2026
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.